Celldex Therapeutics (CLDX) Tops Q2 Loss Views by 2c/Share

August 10, 2012 7:01 AM EDT
Get Alerts CLDX Hot Sheet
Trade CLDX Now!
Join SI Premium – FREE
Celldex Therapeutics (NASDAQ: CLDX) reported Q2 EPS of ($0.23), $0.02 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Celldex Therapeutics (CLDX) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment